Derbyshire Medicines Management and Clinical Policies
MHRA November 2021 - Adrenaline auto-injectors: reminder for prescribers to support safe and effective use.
Emerade 300 and 500 microgram adrenaline auto-injectors have been re-supplied to the market following the implementation of corrective actions – patients and their caregivers should be provided with training and advice specific to their prescribed adrenaline auto-injector. Follow the advice in the Summary of Product Characteristics for dosing considerations and continue to reiterate to patients the importance of carrying 2 in-date adrenaline auto-injectors with them at all times.
MHRA 2017 recommends two adrenaline auto-injectors should be prescribed which patients should carry at all times.
The patient information leaflet can be found at: http://www.medicines.org.uk/emc/PIL.28624.latest.pdf
